BioSpace News Archive

TAE Life Sciences presented in vivo and in vitro boron delivery data using the company’s novel compounds at the 60th Particle Therapy Co-Operative Group Conference, occurring June 27 – July 2, 2022.

Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the appointment of Vivian Liu to the company’s board of directors, effective July 1, 2022.

Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announces the appointment of D. Scott Batty, Jr., M.D. as Chief Medical Officer.

NanoVibronix, Inc . (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it is shifting the majority of its manufacturing operations to Singapore in order to allow scalability increase efficiency and address potential supply chain delays.

Quotient Limited announced the closing of its previously announced underwritten public offering of 32,458,336 ordinary shares and pre-funded warrants to purchase 34,208,331 ordinary share for aggregate gross proceeds of approximately $20.0 million.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, today announced a research collaboration agreement with Harvard Medical School in support of a project led by Joan S. Brugge, PhD, a faculty member.

Care Access, today announced the acquisition of Instituto Brasil de Pesquisa Clínica (IBPClin), a clinical trial center in Rio de Janeiro, Brazil, as the first step to bring its decentralized clinical trial delivery model to Latin America, where hard-to-reach, underserved and traditionally underrepresented communities would gain unprecedented access to clinical trials.

Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced that the International Forum of Allergy & Rhinology published positive four-year results from a VivAer® clinical trial.

Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease.

LigoLab, developers of enterprise software that helps medical laboratories simplify complex processes and scale their operations, become more compliant, and more profitable, has revealed that the LigoLab LIS & RCM Laboratory Operating Platform now features web-based remote ordering and resulting functionality.